Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-30

Clinical Trial Update: Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy in Burkina Faso [Phase 3]

View source ↗

Summary

Clinical trial update for mifepristone and misoprostol used for second-trimester abortion in Burkina Faso (Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MISOPROSTOL (Misoprostol)
  • Mifepristone (mifepristone)

Snippet

Sponsor: Gynuity Health Projects | Conditions: Medical; Abortion, Fetus | Phase 3 | Status: UNKNOWN